3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Sjogren's Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
pembrolizumab
553
Specimen Handling
466
Carboplatin
442
Magnetic Resonance Spectroscopy
430
Cyclophosphamide
415
Cisplatin
397
Radiotherapy
312
Gemcitabine
309
Bevacizumab
309
Paclitaxel
295
Biopsy
259
Drug Therapy
249
Capecitabine
242
fludarabine
239
Oxaliplatin
239
Nivolumab
225
venetoclax
219
Injections
213
Docetaxel
205
Fluorouracil
203
Dexamethasone
186
Radiosurgery
172
Rituximab
158
Pemetrexed
153
Standard of Care
147
durvalumab
143
Leucovorin
139
atezolizumab
138
toripalimab
134
tislelizumab
134
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Interventional
×
belimumab
×
Clear all
NCT06410833
2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4
Recruiting
15 enrolled